Medtronic PLC announced Wednesday plans to separate its diabetes business into a new public company, just as the medical-device company reported quarterly results showing that the business was its ...

Medtronic PLC (NYSE:MDT), a leading player in the medical devices industry with a market capitalization of $103.43 billion, has been navigating a complex landscape of opportunities and challenges ...

Global medical device company Medtronic announced Wednesday that it intends to separate its diabetes business into a standalone company. The new diabetes company will focus on accelerating ...

Under Medtronic’s plan, the new unnamed company will also be publicly traded, Medtronic said. The diabetes business generated nearly $2.8 billion in sales in its most recent fiscal year ...

This strategic decision for both Medtronic and New Diabetes Company will create a more focused Medtronic, with a more simplified portfolio in high margin growth markets. At the same time ...

Medtronic said Wednesday that it plans to spin off its diabetes business in the next 18 months, creating a new diabetes technology company that can offer customers both insulin pumps and ...

A Micra AV pacemaker is on display. (Photo by Tang Yanjun/China News Service via Getty Images) Medtronic (NYSE:MDT) is scheduled to announce its earnings on Wednesday, May 21, 2025. Over the last ...

The industry can be a magnet for expensive recalls and litigation. The only option for compromise: reduce the profit. Across the North American ventilator market, Medtronic’s market share ...

However, to ensure uninterrupted inhibition of therapy, care must be exercised to maintain proper magnet positioning over the implanted device. St. Jude Medical and Medtronic were also asked about ...

VCG / Contributor / Getty Images Medtronic shares slumped Tuesday after the medical device maker missed sales forecasts. The revenue miss came as sales of its stapling and blood oxygen management ...